Question · Q3 2025
Gabriel Dechaine questioned the impact of Mandatory Provident Fund (MPF) fee changes on the GWAM business starting in Q4, asking for details on Manulife's offsetting actions, their effectiveness, and timeline. He also sought clarification on the actuarial review's LTC component, specifically regarding morbidity reserves, expected premium increases, and the nuanced message on medical cost inflation and utilization.
Answer
Paul Lorentz, President and CEO of Manulife Wealth and Asset Management, confirmed the $25 million per quarter guidance for MPF impact remains, with system decommissioning and FTE reductions expected to offset costs by Q2. He noted proactive expense actions already taken. Stephanie Fadous, Chief Actuary, explained the LTC review's modest favorable impact, attributing utilization losses to higher medical inflation, which is reflected as elevated for a longer period. She noted consistent termination gains and conservative premium rate increase assumptions (less than 30% of total outstanding ask).